These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19141763)

  • 21. Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration.
    Allannic H; Fauchet R; Orgiazzi J; Madec AM; Genetet B; Lorcy Y; Le Guerrier AM; Delambre C; Derennes V
    J Clin Endocrinol Metab; 1990 Mar; 70(3):675-9. PubMed ID: 1689737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
    N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graves disease in children: thyroid-stimulating hormone receptor antibodies as remission markers.
    Gastaldi R; Poggi E; Mussa A; Weber G; Vigone MC; Salerno M; Delvecchio M; Peroni E; Pistorio A; Corrias A
    J Pediatr; 2014 May; 164(5):1189-1194.e1. PubMed ID: 24518168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacology and dosage of thyrostatic drugs].
    Passath A; Leb G; Warnkross H
    Acta Med Austriaca; 1987; 14(3-4):72-4. PubMed ID: 2447738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid-stimulation hormone-receptor antibodies as a predictor of thyrosuppressive drug therapy outcome in Graves' disease patients.
    Aleksić AZ; Aleksić Ž; Manić S; Mitov V; Jolić A
    Med Pregl; 2014; 67(9-10):305-11. PubMed ID: 25546977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there one successful antithyroid regimen for Graves' disease?
    Braverman LE
    Lancet; 1996 Sep; 348(9029):697-8. PubMed ID: 8806285
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' disease.
    Edan G; Massart C; Hody B; Poirier JY; Lé Reun M; Hespel JP; Leclech G; Simon M
    BMJ; 1989 Feb; 298(6670):359-61. PubMed ID: 2564286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of remission in Graves' disease treated with long-term carbimazole therapy: evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators.
    Prakash R
    Eur J Nucl Med; 1996 Feb; 23(2):118-22. PubMed ID: 8925844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Bucci I; Carpentieri M; Di Nenno B; Di Blasio A; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of iodine-131-induced early thyroid hormone variations in Graves' disease.
    Xu F; Gu A; Pan Y; Yang L; Ma Y
    Nucl Med Commun; 2016 Nov; 37(11):1154-9. PubMed ID: 27366942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Maternal and cord blood thyroid hormones in Graves' disease and fetal states].
    Koike S; Aoyama A; Yamaguchi N; Natori Y; Suzuki T; Itou M; Kusakabe K; Demura R
    Rinsho Byori; 1993 Jun; 41(6):666-72. PubMed ID: 7689666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graves disease associated with autoimmune thrombocytopenic purpura.
    Hofbauer LC; Spitzweg C; Schmauss S; Heufelder AE
    Arch Intern Med; 1997 May; 157(9):1033-6. PubMed ID: 9140276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of short-term treatment of Graves' disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole.
    Grebe SK; Feek CM; Ford HC; Fagerström JN; Cordwell DP; Delahunt JW; Toomath RJ
    Clin Endocrinol (Oxf); 1998 May; 48(5):585-92. PubMed ID: 9666870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
    Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis.
    Dalan R; Leow MK; Ng DC
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):612-5. PubMed ID: 18941129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smoking.
    Nedrebø BG; Hustad S; Schneede J; Ueland PM; Vollset SE; Holm PI; Aanderud S; Lien EA
    J Intern Med; 2003 Nov; 254(5):504-12. PubMed ID: 14535973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of Graves-Basedow disease with carbimazole and dexamethasone. Effect on thyroid hormones].
    Obiols Alfonso G; Mesa Manteca J; García Pascual L; Simo Canonge R; Faigón Schprejer L; Tresánchez Trías JM
    Rev Clin Esp; 1987 Apr; 180(6):296-9. PubMed ID: 3602535
    [No Abstract]   [Full Text] [Related]  

  • 40. Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.
    Liu X; Shi B; Li H
    Ann Endocrinol (Paris); 2015 Dec; 76(6):679-83. PubMed ID: 26514949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.